BWA vs CTXR · P/E 41, rev $7.18B vs rev $7.1M
BorgWarner Inc (BWA) versus Citius Pharmaceuticals Inc (CTXR) — a side-by-side from cached financials, not a winner call.
BorgWarner Inc (BWA) is a auto parts company listed on NYSE.
Citius Pharmaceuticals Inc (CTXR) is a biotechnology company listed on US.
Latest reported BWA revenue for 2026-06-30 was $7.18B. Net income was $519.0M. BWA currently screens at market cap $14.47B and trailing P/E 41.0.
Latest reported CTXR revenue for 2026-06-30 was $7.1M. Net income was -$49.4M. Revenue was up 26.6% from 2026-03-31 to 2026-06-30. CTXR currently screens at market cap $13.4M.
BWA currently screens at market cap $14.47B and trailing P/E 41.0. CTXR currently screens at market cap $13.4M.
Not investment advice. Open the BWA and CTXR stock pages for the full models.
Not investment advice.